Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Marginal Effect and Little Clinical Relevance.

× No keyword cloud information.

4 in total

1. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma.

Authors: Jose Bardelas; Maria Figliomeni; Farid Kianifard; Xiangyi Meng
Journal: J Asthma Date: 2012-01-25 Impact factor: 2.515

Review 2. Severe asthma: definition, diagnosis and treatment.

Authors: Marek Lommatzsch; J Christian Virchow
Journal: Dtsch Arztebl Int Date: 2014-12-12 Impact factor: 5.594

3. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Authors: Nicola A Hanania; Oral Alpan; Daniel L Hamilos; John J Condemi; Irmarie Reyes-Rivera; Jin Zhu; Karin E Rosen; Mark D Eisner; Dennis A Wong; William Busse
Journal: Ann Intern Med Date: 2011-05-03 Impact factor: 25.391

4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Authors: M Humbert; R Beasley; J Ayres; R Slavin; J Hébert; J Bousquet; K-M Beeh; S Ramos; G W Canonica; S Hedgecock; H Fox; M Blogg; K Surrey
Journal: Allergy Date: 2005-03 Impact factor: 13.146

4 in total